Study details
Enrolling now
Escitalopram for Asthma Exacerbations
University of Texas Southwestern Medical Center
NCT IDNCT06216535ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
105
Study length
about 4 years
Ages
18–75
Locations
1 site in TX
What this study is about
This trial is testing whether escitalopram helps reduce asthma exacerbations in adults with frequent attacks. Participants will take either escitalopram or a placebo, and the number of asthma exacerbations will be tracked over 1474 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Escitalopram
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
escitalopram (SSRI; increases serotonin availability)
Drug routes
oral (Oral Tablet)
Body systems
Respiratory